Print Page | Close Window

2015 News Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009
DateTitle 
06/02/15GTx Regains Compliance with NASDAQ Bid Price Requirement
MEMPHIS, Tenn.--(BUSINESS WIRE)--Jun. 2, 2015-- GTx, Inc. (Nasdaq: GTXI) today announced that it has received written communication from the NASDAQ Listing Qualifications Panel that the Company has regained compliance with the minimum bid price requirement under the NASDAQ Listing Rules as a result of the closing bid price of GTx’s common stock having been at or above the minimum requirement of $1.00 per share for a minimum of ten consecutive trading day... 
Printer Friendly Version
05/26/15GTx Announces Webcast of Corporate Presentation at Jefferies 2015 Global Healthcare Conference
MEMPHIS, Tenn.--(BUSINESS WIRE)--May 26, 2015-- GTx, Inc. (Nasdaq: GTXI) announced today that Dr. Robert J. Wills, Executive Chairman of GTx, will present a company overview on June 2, 2015, at the Jefferies 2015 Global Healthcare Conference in New York City. The GTx presentation will begin at 8:00 am EDT. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation wi... 
Printer Friendly Version
05/12/15GTx Announces Webcast of Corporate Presentation at the UBS Global Healthcare Conference 2015
MEMPHIS, Tenn.--(BUSINESS WIRE)--May 12, 2015-- GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on May 19, 2015, at the UBS Global Healthcare Conference in New York City. The GTx presentation will begin at 4:00 pm EDT. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website un... 
Printer Friendly Version
05/08/15GTx Provides Corporate Update and Reports First Quarter 2015 Financial Results
Company to initiate two open-label Phase 2 clinical trials of enobosarm in breast cancer Company undertakes studies to optimize SARD compounds for further development Conference call today at 9:00 a.m. Eastern Time MEMPHIS, Tenn.--(BUSINESS WIRE)--May 8, 2015-- GTx, Inc. (Nasdaq: GTXI) today reported financial results for the first quarter ended March 31, 2015, and highlighted recent accomplishments and upcoming ... 
Printer Friendly Version
04/23/15GTx and the University of Tennessee Research Foundation Enter Into Exclusive License Agreement to Develop UTRF’s SARD Drug Technology
SARD technology may potentially degrade and inhibit all forms of androgen receptor, including those resistant to current therapies GTx to provide quarterly corporate update and financial results on conference call on May 8, 2015 MEMPHIS, Tenn.--(BUSINESS WIRE)--Apr. 23, 2015-- GTx, Inc. (NASDAQ: GTXI) today announced that it has entered into an exclusive worldwide license agreement with the University of Tennessee Research Foun... 
Printer Friendly Version
04/02/15GTx Provides Corporate Update Regarding NASDAQ Stock Listing
-Request to transfer stock listing to NASDAQ capital market approved- -Company receives 180-day extension to comply with NASDAQ bid price requirement- MEMPHIS, Tenn.--(BUSINESS WIRE)--Apr. 2, 2015-- GTx, Inc. (Nasdaq: GTXI) today provided an update regarding the initiatives being taken to address the Company's continued listing on The NASDAQ Capital Market. As previously reported, on October 8, 2014, the Company received correspondence... 
Printer Friendly Version
03/04/15GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results
Company to initiate two open-label Phase 2 clinical trials of enobosarm for two breast cancer indications Conference call today at 9:00 a.m. ET MEMPHIS, Tenn.--(BUSINESS WIRE)--Mar. 4, 2015-- GTx, Inc. (Nasdaq: GTXI) today reported financial results for the fourth quarter and year ended December 31, 2014, and highlighted recent accomplishments and upcoming milestones. The Company remains focused on targeting the androgen receptor in ... 
Printer Friendly Version
02/19/15GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast
MEMPHIS, Tenn.--(BUSINESS WIRE)--Feb. 19, 2015-- GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company’s fourth quarter and full year 2014 financial results on Wednesday, March 4, at 9:00 a.m. Eastern Time. The call and webcast will follow the release of the financial results earlier that day. To listen to the conference call, please dial: ... 
Printer Friendly Version
02/17/15GTx Appoints Robert J. Wills, Ph.D. to Board of Directors
– Industry Veteran to serve as Executive Chairman of the Board and Chair of the Board’s Scientific and Development Committee – MEMPHIS, Tenn.--(BUSINESS WIRE)--Feb. 17, 2015-- GTx, Inc. (NASDAQ: GTXI) today announced that Robert J. Wills, Ph.D., has been appointed to the Company's Board of Directors and will serve as GTx’s Executive Chairman as well as the Chairman of the Board’s Scientific and Development Committee, in each case effective March 2, ... 
Printer Friendly Version